RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Karl Miletti-Gonzalez to Drug Resistance, Neoplasm

Back to Details
This is a "connection" page, showing publications Karl Miletti-Gonzalez has written about Drug Resistance, Neoplasm.
Karl Miletti-Gonzalez
Connection Strength
0.114
Drug Resistance, Neoplasm
  1. Ravindranath AK, Kaur S, Wernyj RP, Kumaran MN, Miletti-Gonzalez KE, Chan R, Lim E, Madura K, Rodriguez-Rodriguez L. CD44 promotes multi-drug resistance by protecting P-glycoprotein from FBXO21-mediated ubiquitination. Oncotarget. 2015 Sep 22; 6(28):26308-21.
    View in: PubMed
    Score: 0.114
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support